Myasthenia gravis patients with low plasma IL-6 and IFN-γ benefit from etanercept treatment

Erdem Tüzün, Matthew N. Meriggioli, Julie Rowin, Huan Yang, Premkumar Christadoss

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'Myasthenia gravis patients with low plasma IL-6 and IFN-γ benefit from etanercept treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences